|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 257/02 | (2006.01) |
| C07C 229/16 | (2006.01) | ||
| A61K 49/10 | (2006.01) |
| (11) | Number of the document | 3611169 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19194723.3 |
| Date of filing the European patent application | 2016-05-30 | |
| (97) | Date of publication of the European application | 2020-02-19 |
| (45) | Date of publication and mention of the grant of the patent | 2021-07-21 |
| (46) | Date of publication of the claims translation | 2021-10-11 |
| (30) | Number | Date | Country code |
| 15170658 | 2015-06-04 | EP |
| (72) |
Berger, Markus , DE
Lohrke, Jessica , DE
Hilger, Christoph-Stephan , DE
Jost, Gregor , DE
Fenzel, Thomas , DE
Suelzle, Detlev , DE
Platzek, Johannes , DE
Panknin, Olaf , DE
Pietsch, Hubertus , DE
|
| (73) |
Bayer Pharma Aktiengesellschaft ,
Müllerstrasse 178, 13353 Berlin,
DE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Nauji gadolinio chelatiniai junginiai, skirti naudoti magnetinio rezonanso tomografijoje |
| NEW GADOLINIUM CHELATE COMPOUNDS FOR USE IN MAGNETIC RESONANCE IMAGING |
| Payment date | Validity (years) | Amount | |
| 2025-04-24 | 10 | 231.00 EUR |
| 2026-05-30 |